Current knowledge on hepatitis E

Journal of Clinical and Translational Hepatology

Volumn 3, Issue 2, 2015, Pages 117-126

  Pérez Gracia, María Teresa ^a   García, Mario ^a   Suay, Beatriz ^a   Mateos Lindemann, María Luisa ^b  

^a UNIVERSIDAD CEU CARDENAL HERRERA   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Hepatitis E; Hepatitis E virus; HEV; Zoonosis

Indexed keywords

EID: 85093887849     PISSN: 22250719     EISSN: 23108819     Source Type: Journal    
DOI: 10.14218/JCTH.2015.00009     Document Type: Review

References (119)

1. Pérez-Gracia MT, Mateos-Lindemann ML. Hepatitis E. Current perspectives. Med Clin (Barc) 2012;139:404–411. doi: 10.1016/j.medcli.2012.02.013.
2. Pérez-Gracia MT, Mateos Lindemann ML, Montalvo Villalba M C. Hepatitis E: current status. Rev Med Virol 2013;23:384–398. doi: 10.1002/rmv.1759.
3. Balayan MS, Andjaparidze AG, Savinskaya SS, Ketiladze ES, Braginsky DM, Savinov AP, et al. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology 1983;20:23–31.
4. Reyes GR, Purdy MA, Kim JP, Luk KC, Young LM, Fry KE, et al. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science 1990;247:1335–1339.
5. Yarbough PO, Tam AW, Fry KE, Krawczynski K, McCaustland KA, Bradley DW, et al. Hepatitis E Virus: identification of type-common epitopes. J Virol 1991; 65:5790–5797. doi: 0022-538X/91/115790-08$02.00/0.
6. Arankalle VA, Tsarev SA, Chadha MS, Alling DW, Emerson SU, Banerjee K, et al. Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992. J Infect Dis 1995;171:447–450.
7. Purcell RH, Emerson SU. Hepatitis E: an emerging awareness of an old dis-ease. J Hepatol 2008;48:494–503. doi: 10.1016/j.jhep.2007.12.008.
8. Pérez-Gracia MT, Mateos ML, Galiana C, Fernández-Barredo S, García A, Gómez MT, et al. Autochthonous hepatitis E infection in a slaughterhouse worker. Am J Trop Med Hyg 2007;77:893–896.
9. Mateos Lindemann ML, Morales JG, Fernández-Barredo S, Domínguez MR, García de la Hoz F, Halfon P, et al. Fulminant hepatitis E in a woman taking oral contraceptive medication. Am J Trop Med Hyg 2010;82:12–15. doi: 10. 4269/ajtmh.2010.09-0436.
10. Miyashita K, Kang JH, Saga A, Takahashi K, Shimamura T, Yasumoto A, et al. Three cases of acute or fulminant hepatitis E caused by ingestion of pork meat and entrails in Hokkaido, Japan: Zoonotic food-borne transmission of hepatitis E virus and public health concerns. Hepatol Res 2012;42:870– 878. doi: 10.1111/j.1872-034X.2012.01006.x.
11. Li TC, Yamakawa Y, Suzuki K, Tatsumi M, Razak MA, Uchida T, et al. Expression and self-assembly of empty virus-like particles of hepatitis E virus. J Virol 1997;71:7207–7213.
12. Tam AW, Smith MM, Guerra ME, Huang CC, Bradley DW, Fry KE, et al. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 1991;185:120–131. doi: 10.1016/0042-6822(91) 90760-9.
13. Parvez MK, Al-Dosari MS. Evidence of MAPK-JNK1/2 activation by hepatitis E virus ORF3 protein in cultured hepatoma cells. Cytotechnology 2015;67: 545–550. doi: 10.1007/s10616-014-9785-1.
14. Khudyakov YE, Favorov MO, Khudyakova NS, Cong ME, Holloway BP, Padhye N, et al. Artificial mosaic protein containing antigenic epitopes of hepatitis E virus. J Virol 1994;68:7067–7074.
15. Schlauder GG, Mushahwar IK. Genetic heterogeneity of hepatitis E virus. J Med Virol 2001;2:282–292. doi: 10.1002/jmv.2031.
16. Lu L, Li C, Hagedorn CH. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev Med Virol 2006; 16:5–36. doi: 10.1002/rmv.482.
17. Smith DB, Simmonds P, International Committee on Taxonomy of Viruses Hepeviridae Study Group, Jameel S, Emerson SU, Harrison TJ, et al. Consensus proposals for classification of the family Hepeviridae. J Gen Virol 2014;95:2223–2232. doi: 10.1099/vir.0.068429-0.
18. Meng XJ, Purcell RH, Halbur PG, Lehman JR, Webb DM, Tsareva TS, et al. A novel virus in swine is closely related to the human hepatitis E virus. Proc Natl Acad Sci USA 1997;94:9860–9865.
19. Yoo D, Willson P, Pei Y, Hayes MA, Deckert A, Dewey CE, et al. Prevalence of hepatitis E virus antibodies in Canadian swine herds and identification of a novel variant of swine hepatitis E virus. Clin Diagn Lab Immunol 2001;6: 1213–1219. doi: 10.1128/CDLI.8.6.1213-1219.
20. Schlauder GG, Frider B, Sookoian S, Castano GC, Mushahwar IK. Identification of 2 novel isolates of hepatitis E virus in Argentina. J Infect Dis 2000; 1:294–297. doi: 10.1086/315651.
21. Pérez-Gracia MT, Garcia-Valdivia MS, Galan F, Rodriguez-Iglesias MA. Detection of hepatitis E virus in patients sera in southern Spain. Acta Virol 2004;48:197–200.
22. Fernandez-Barredo S, Galiana C, Garcia A, Vega S, Gomez MT, Perez-Gracia MT. Detection of hepatitis E virus shedding in feces of pigs at different stages of production using reverse transcription-polymerase chain reaction. J Vet Diagn Invest 2006;18:462–465.
23. Mansuy JM, Abravanel F, Miedouge M, Mengelle C, Merviel C, Dubois M, et al. Acute hepatitis E in south-west France over a 5-year period. J Clin Virol 2009;44:74–77. doi: 10.1016/j.jcv.2008.09.010.
24. Banks M, Bendall R, Grierson S, Heath G, Mitchell J, Dalton H. Human and porcine hepatitis E virus strains, United Kingdom. Emerg Infect Dis 2004;5: 953–955. doi: 10.3201/eid1005.030908.
25. Worm HC, Schlauder GG, Wurzer H, Mushahwar IK. Identification of a novel variant of hepatitis E virus in Austria: sequence, phylogenetic and serological analysis. J Gen Virol 2000;12:2885–2890.
26. Van der Poel WH, Verschoor F, van der Heide R, Herrera MI, Vivo A, Koore-man M, et al. Hepatitis E virus sequences in swine related to sequences in humans, The Netherlands. Emerg Infect Dis 2001;6:970–976. doi: 10. 3201/eid0706.010608.
27. Garkavenko O, Obriadina A, Meng J, Anderson DA, Benard HJ, Schroeder BA, et al. Detection and characterisation of swine hepatitis E virus in New Zealand. J Med Virol 2001;65:525–529. doi: 10.1002/jmv.2067.
28. Bouamra Y, Gérolami R, Arzouni JP, Grimaud JC, Lafforgue P, Nelli M, et al. Emergence of autochthonous infections with hepatitis E virus of genotype 4 in Europe. Intervirology 2014;57:43–48. doi: 10.1159/000354801.
29. Monne I, Ceglie L, DI Martino G, Natale A, Zamprogna S, Morreale A, et al. Hepatitis E virus genotype 4 in a pig farm, Italy, 2013. Epidemiol Infect 2015;143:529–533. doi: 10.1017/S0950268814001150.
30. Pérez-Gracia MT, Suay B, Mateos-Lindemann ML. Hepatitis E: an emerging disease. Infect Genet Evol 2014;22:40–59. doi: 10.1016/j.meegid.
31. Emerson SU, Purcell RH. Hepatitis E virus. Rev Med Virol 2003;13:145–154. doi: 10.1002/rmv.384.
32. Teshale EH, Hu DJ, Holmberg SD. The Two Faces of Hepatitis E Virus. Clin Infect Dis 2010;51:328–334. doi: 10.1086/653943.
33. Ducancelle A, Payan C, Nicand E, Le Guillou H, Calès P, Lunel-Fabiani F. Intrafamilial hepatitis E in France. J Clin Virol 2007;39:51–53. doi: 10. 1016/j.jcv.2007.02.007.
34. Piper-Jenks N, Horowitz HW, Schwartz E. Risk of hepatitis E infection to travellers. J Travel Med 2000;4:194–199. doi: 10.2310/7060.2000.00059.
35. Ijaz S, Arnold E, Banks M, Bendal RP, Cramp ME, Cunningham R, et al. Non-travel-associated hepatitis E in England and wales: demographic, clinical, and molecular epidemiological characteristics. J Infect Dis 2005;7:1166– 1172. doi: 10.1086/444396.
36. Echevarría JM, Fogeda M, Avellón A. Diagnosis of acute hepatitis E by antibody and molecular testing: a study on 277 suspected cases. J Clin Virol 2011;50:69–71. doi: 10.1016/j.jcv.2010.09.016.
37. Meng XJ, Halbur PG, Shapiro MS, Govindarajan S, Bruna JD, Mushahwar IK, et al. Genetic and experimental evidence for cross-species infection by swine hepatitis E virus. J Virol 1998;72:9714–9721.
38. Thomas DL, Yarbough PO, Vlahov D, Tsarev SA, Nelson KE, Saah AJ, et al. Seroreactivity to hepatitis E virus in areas where the disease is not endemic. J Clin Microbiol 1997;35:1244–1247.
39. Usmanov RK, Balaian MS, Dvoinikova OV, Alymbaeva DB, Zamiatina NA, Kazachkov, et al. [An experimental infection in lambs by the hepatitis E virus]. Vopr Virusol 1994;4:165–168.
40. Maneerat Y, Clayson ET, Myint KS, Young GD, Innis BL. Experimental infection of the laboratory rat with the hepatitis E virus. J Med Virol 1996;2:121– 128.
41. Clayson ET, Innis BL, Myint KS, Narupiti S, Vaughn DW, Giri S, et al. Detection of hepatitis E virus infections among domestic swine in the Kathmandu Valley of Nepal. Am J Trop Med Hyg 1995;53:228–232.
42. Cooper K, Huang FF, Batista L, Rayo CD, Bezanilla JC, Toth TE, et al. Identification of genotype 3 hepatitis E virus (HEV) in serum and fecal samples from pigs in Thailand and Mexico, where genotype 1 and 2 HEV strains are prevalent in the respective human populations. J Clin Microbiol 2005;43: 1684–1688. doi: 10.1128/JCM.43.4.1684-1688.
43. Choi IS, Kwon HJ, Shin NR, Yoo HS. Identification of swine hepatitis E virus (HEV) and prevalence of anti-HEV antibodies in swine and human populations in Korea. J Clin Microbiol 2003;8:3602–3608. doi: 10.1128/JCM.41.8. 3602-3608.
44. Wu JC, Chen CM, Chiang TY, Tsai WH, Jeng WJ, Sheen IJ, et al. Spread of hepatitis E virus among different-aged pigs: two-year survey in Taiwan. J Med Virol 2002;4:488–492. doi: 10.1002/jmv.2170.
45. Sun ZF, Larsen CT, Huang FF, Billam P, Pierson FW, Toth TE, et al. Generation and infectivity titration of an infectious stock of avian hepatitis E virus (HEV) in chickens and cross-species infection of turkeys with avian HEV. J Clin Microbiol 2004;42:2658–2662. doi: 10.1128/JCM.42.6.2658-2662.
46. Arankalle VA, Joshi MV, Kulkarni AM, Gandhe SS, Chobe LP, Rautmare SS, et al. Prevalence of anti-hepatitis E virus antibodies in different Indian animal species. J Viral Hepat 2001;8:223–227. doi: 10.1046/j.1365-2893. 2001.00290.x.
47. Vitral CL, Pinto MA, Lewis-Ximenez LL, Khudyakov YE, dos Santos DR, Gas-par AM. Serological evidence of hepatitis E virus infection in different animal species from the Southeast of Brazil. Mem Inst Oswaldo Cruz 2005;2:117– 122. doi: 10.1590/S0074-02762005000200003.
48. Sonoda H, Abe M, Sugimoto T, Sato Y, Bando M, Fukui E, et al. Prevalence of hepatitis E virus (HEV) Infection in wild boars and deer and genetic identification of a genotype 3 HEV from a boar in Japan. J Clin Microbiol 2004;42: 5371–5374. doi: 10.1128/JCM.42.11.5371-5374.
49. Kuno A, Ido K, Isoda N, Satoh Y, Ono K, Satoh S, et al. Sporadic acute hepatitis E of a 47-year-old man whose pet cat was positive for antibody to hepatitis E virus. Hepatology Research 2003;3:237–242.
50. Favorov MO, Kosoy MY, Tsarev SA, Childs JE, Margolis HS. Prevalence of antibody to hepatitis E virus among rodents in the United States. J Infect Dis 2000;181:449–455. doi: 10.1086/315273.
51. Kabrane-Lazizi Y, Fine JB, Elm J, Glass GE, Higa H, Diwan A, et al. Evidence for widespread infection of wild rats with hepatitis E virus in the United States. Am J Trop Med Hyg 1999;61:331–335.
52. Nakamura M, Takahashi K, Taira K, Taira M, Ohno A, Sakugawa H, et al. Hepatitis E virus infection in wild mongooses of Okinawa, Japan: demon-stration of anti-HEV antibodies and a full-genome nucleotide sequenc. Hep-atol Res 2006;34:137–140.
53. Haqshenas G, Shivaprasad HL, Woolcock PR, Read DH, Meng XJ. Genetic identification and characterization of a novel virus related to human hepatitis E virus from chickens with hepatitis-splenomegaly syndrome in the United States. J Gen Virol 2001;82:2449–2462.
54. Saad MD, Hussein HA, Bashandy MM, Kamel HH, Earhart KC, Fryauff DJ, et al. Hepatitis E virus infection in work horses in Egypt. Infect, Genet Evol 2007;7:368–373. doi: 10.1016/j.meegid.2006.07.007.
55. Takahashi M, Nishizawa T, Miyajima H, Gotanda Y, Iita T, Tsuda F, et al. Swine hepatitis E virus strains in Japan form four phylogenetic clusters comparable with those of Japanese isolates of human hepatitis E virus. J Gen Virol 2003;4:851–862. doi: 10.1099/vir.0.18918-0.
56. Li W, Guan D, Su J, Takeda N, Wakita T, Li TC, et al. High prevalence of rat hepatitis E virus in wild rats in China. Vet Microbiol 2013;165:275–280. doi: 10.1016/j.vetmic.2013.03.017.
57. Zhao C, Ma Z, Harrison TJ, Feng R, Zhang C, Qiao Z, et al. A novel genotype of hepatitis E virus prevalent among farmed rabbits in China. J Med Virol 2009;81:1371–1379. doi: 10.1002/jmv.21536.
58. Wu J, Si F, Jiang C, Li T, Jin M. Molecular detection of hepatitis E virus in sheep from southern Xinjiang, China. Virus Genes 2015;50:410–417. doi: 10.1007/s11262-015-1194-9.
59. Ahn JM, Kang SG, Lee DY, Shin SJ, Yoo HS. Identification of novel human hepatitis E virus (HEV) isolates and determination of the seroprevalence of HEV in Korea. J Clin Microbiol 2005;7:3042–3048. doi: 10.1128/JCM.43.7. 3042–3048.
60. Ijaz S, Arnold E, Banks M, Bendal RP, Cramp ME, Cunningham R, et al. Non-travel-associated hepatitis E in England and wales: demographic, clinical, and molecular epidemiological characteristics. J Infect Dis 2005;7:1166– 1172. doi: 10.1086/444396.
61. Hsieh SY, Meng XJ, Wu YH, Liu ST, Tam AW, Lin DY, et al. Identity of a novel swine hepatitis E virus in Taiwan forming a monophyletic group with Taiwan isolates of human hepatitis E virus. J Clin Microbiol 1999;37:3828–3834.
62. Yazaki Y, Mizuo H, Takahashi M, Nishizawa T, Sasaki N, Gotanda Y, et al. Sporadic acute or fulminant hepatitis E in Hokkaido, Japan, may be food-borne, as suggested by the presence of hepatitis E virus in pig liver as food. J Gen Virol 2003;84:2351–2357. doi: 10.1099/vir.0.19242-0.
63. Tei S, Kitajima N, Takahashi K, Mishiro S. Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet 2003;362:371–373. doi: 10. 1016/S0140-6736(03)14025-1.
64. Withers MR, Correa MT, Morrow M, Stebbins ME, Seriwatana J, Webster WD, et al. Antibody levels to hepatitis E virus in North Carolina swine workers, non-swine workers, swine, and murids. Am J Trop Med Hyg 2002;66:384– 388.
65. Galiana C, Fernandez-Barredo S, Garcia A, Gomez MT, Perez-Gracia MT. Occupational exposure to hepatitis E virus (HEV) in swine workers. Am J Trop Med Hyg 2008;78:1012–1015.
66. Galiana C, Fernandez-Barredo S, Perez-Gracia MT. Prevalence of hepatitis E virus (HEV) and risk factors in pig workers and blood donors. Enferm Infect Microbiol Clin 2010;28:602–607. doi: 10.1016/j.eimc.2010.01.010.
67. Hewitt PE, Ijaz S, Brailsford SR, Brett R, Dicks S, Haywood B, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet 2014;384:1766–1773. doi: 10.1016/S0140-6736(14)61034-5.
68. Kumar S, Subhadra S, Singh B, Panda BK. Hepatitis E virus: the current scenario. Int J Infect Dis 2013;17:e228–e233. doi: 10.1016/j.ijid.2012. 11.026.
69. Krain LJ, Atwell JE, Nelson KE, Labrique AB. Fetal an neonatal health con-sequences of vertically transmitted hepatitis E virus infection. Am J Trop Med Hyg 2014;90:365–370. doi: 10.4269/ajtmh.13-0265.
70. Aggarwal R, Kini D, Sofat S, Naik SR, Krawczynski K. Duration of viraemia and faecal viral excretion in acute hepatitis E. Lancet 2000;356:1081– 1082. doi: 10.1016/S0140-6736(00)02737-9.
71. Krawczynski K, Aggarwal R, Kamili S. Hepatitis E. Infect Dis Clin North Am 2000;14:669–687.
72. Hussaini SH, Skidmore SJ, Richardson P, Sherratt LM, Cooper BT, O’Grady JG. Severe hepatitis E infection during pregnancy. J Viral Hepat 1997;4:51– 54.
73. Khuroo MS, Kamili S, Jameel S. Vertical transmission of hepatitis E virus. Lancet 1995;345:1025–1026.
74. Renou C, Pariente A, Nicand E, Pavio N. Pathogenesis of hepatitis E in preg-nancy. Liver Int 2008;28:1465; author reply 1466. doi: 10.1111/j.1478-3231.2008.01885.x.
75. Ohnishi S, Kang JH, Maekubo H, Arakawa T, Karino Y, Toyota J, et al. Comparison of clinical features of acute hepatitis caused by hepatitis E virus (HEV) genotypes 3 and 4 in Sapporo, Japan. Hepatol Res 2006;36:301– 307.
76. Kamar N, Selves J, Mansuy JM, Ouezzani L, Peron JM, Guitard J, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008;358:811–817. doi: 10.1056/NEJMoa0706992.
77. Le Coutre P, Meisel H, Hofmann J, Rocken C, Vuong GL, Neuburger S, et al. Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation. Gut 2009;58:699– 702. doi: 10.1136/gut.2008.165571.
78. Kamar N, Mansuy JM, Cointault O, Selves J, Abravanel F, Danjoux M, et al. Hepatitis E virus-related cirrhosis in kidney-and kidney-pancreas-trans-plant recipients. Am J Transplant 2008;8:1744–1748. doi: 10.1111/j. 1600-6143.2008.02286.x.
79. Mateos-Lindemann ML, Gonzalez-Galdámez A, Bordallo-Cardona M, Pérez-Gracia MT. Are HIV-infected patients a high-risk population for hepatitis E virus infection in Spain? Enferm Infecc Microbiol Clin 2012;30:582–583. doi: 10.1016/j.eimc.2012.03.010.
80. Mateos-Lindemann ML, Diez-Aguilar M, Galdamez AL, Galán JC, Moreno A, Pérez-Gracia MT. Patients infected with HIV are at high-risk for hepatitis E virus infection in Spain. J Med Virol 2014;86:71–74. doi: 10.1002/jmv. 23804.
81. Madejon A, Vispo E, Bottecchia M, Sanchez-Carrillo M, Garcia-Samaniego J, Soriano V. Lack of hepatitis E virus infection in HIV patients with advanced immunodeficiency or idiopathic liver enzyme elevations. J Viral Hepat 2009; 16:895–896. doi: 10.1111/j.1365-2893.2009.01138.x.
82. Renou C, Lafeuillade A, Pavio N, Nicand E. Response to Madejon et al.: Are HIV-infected patients at risk of HEV infection? J Viral Hepat 2010;17:380. doi: 10.1111/j.1365-2893.2009.01203.x.
83. Colson P, Dhiver C, Gerolami R. Hepatitis E virus as a newly identified cause of acute viral hepatitis during human immunodeficiency virus infection. Clin Microbiol Infect 2008;14:1176–1180. doi: 10.1111/j.1469-0691.2008. 02102.x.
84. Thoden J, Venhoff N, Miehle N, Klar M, Huzly D, Panther E, et al. Hepatitis E and jaundice in an HIV-positive pregnant woman. AIDS 2008;22:909–910. doi: 10.1097/QAD.0b013e3282f7cb9a.
85. Mateos-Lindemann ML, Diez-Aguilar M, González-Galdamez A, Graus-Morales J, Moreno-Zamora A, Pérez-Gracia MT. Acute, chronic and fulminant hepatitis E: Seven years of experience (2004-2011). Enferm Infecc Microbiol Clin 2013;31:595–598. doi: 10.1016/j.eimc.2013.03.014.
86. Bigaillon C, Tesse S, Lagathu G, Nicand E. Use of hepatitis E IgG avidity for diagnosis of hepatitis E infection. J Virol Methods 2009;164:127–130. doi: 10.1016/j.jviromet.2009.11.028.
87. Legrand-Abravanel F, Thevenet I, Mansuy JM, Saune K, Vischi F, Peron JM, et al. Good performance of immunoglobulin M assays in diagnosing genotype 3 hepatitis E virus infections. Clin Vaccine Immunol 2009;16: 772–774. doi:10.1128/CVI.00438-08.
88. Peron JM, Danjoux M, Kamar N, Missoury R, Poirson H, Vinel JP, et al. Liver histology in patients with sporadic acute hepatitis E: a study of 11 patients from south-west France. Virchows Arch 2007;450:405–410.
89. Malcolm P, Dalton H, Hussaini HS, Mathew J. The histology of acute autoch-thonous hepatitis E virus infection. Histopathology 2007;51:190–194. doi: 10.1111/j.1365-2559.2007.02756.x.
90. Lockwood GL, Fernandez-Barredo S, Bendall R, Banks M, Ijaz S, Dalton HR. Hepatitis E autochthonous infection in chronic liver disease. Eur J Gastroenterol Hepatol 2008;20:800–803. doi: 10.1097/MEG.0b013e3282f1cbff.
91. Haagsma EB, van den Berg AP, Porte RJ, Benne CA, Vennema H, Reimerink JH, et al. Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl 2008;14:547–553. doi: 10.1002/lt.21480.
92. Shinde NR, Patil TB, Deshpande AS, Gulhane RV, Patil MB, Bansod YV. Clinical Profile, Maternal and Fetal Outcomes of Acute Hepatitis E in Pregnancy. Ann Med Health Sci Res 2014;4:S133–S139. doi: 10.4103/2141-9248. 138033.
93. Navaneethan U. Seroprevalence of hepatitis E infection in pregnancy-More questions than answers. Indian J Med Res 2009;130:677–679.
94. Gurley ES, Halder AK, Streatfield PK, Sazzad HM, Huda TM, Hossain MJ, et al. Estimating the burden of maternal and neonatal deaths associated with jaundice in Bangladesh: Possible role of hepatitis E infection. Am J Public Health 2012;102:2248–2254. doi: 10.2105/AJPH.2012.300749.
95. Navaneethan U, Al Mohajer M, Shata MT. Hepatitis E and pregnancy: Understanding the pathogenesis. Liver Int 2008;28:1190–1199. doi: 10.1111/j. 1478-3231.2008.01840.x.
96. Mufti AR, Reau N. Liver disease in pregnancy. Clin Liver Dis 2012;16:247– 269. doi: 10.1016/j.cld.2012.03.011.
97. Abraham P. Viral hepatitis in India. Clin Lab Med 2012;32:159–174. doi: 10. 1016/j.cll.2012.03.003.
98. Devhare PB, Chatterjee SN, Arankalle VA, Lole KS. Analysis of antiviral response in human epithelial cells infected with hepatitis E virus. PLoS One 2013;8:e63793. doi: 10.1371/journal.pone.0063793.
99. Tripathy AS, Das R, Rathod SB, Arankalle VA. Cytokine profiles, CTL response and T cell frequencies in the peripheral blood of acute patients and individuals recovered from hepatitis E infection. PLoS One 2012;7: e31822. doi: 10.1371/journal.pone.0031822.
100. Srivastava R, Aggarwal R, Jameel S, Puri P, Gupta VK, Ramesh VS, et al. Cellular immune responses in acute hepatitis E virus infection to the viral open reading frame 2 protein. Viral Immunol 2007;20:56–65. doi: 10. 1089/vim.2006.0053.
101. Bose PD, Das BC, Hazam RK, Kumar A, Medhi S, Kar P. Evidence of extra-hepatic replication of hepatitis E virus in human placenta. J Gen Virol 2014; 95:1266–1271. doi: 10.1099/vir.0.063602-0.
102. Xia J, Liu L, Wang L, Zhang Y, Zeng H, Liu P, et al. Experimental infection of pregnant rabbits with hepatitis E virus demonstrating high mortality and vertical transmission. J Viral Hepat 2015. doi: 10.1111/jvh.12406.
103. Inoue J, Takahashi M, Yazaki Y, Tsuda F, Okamoto H. Development and validation of an improved RT-PCR assay with nested universal primers for detection of hepatitis E virus strains with significant sequence divergence. J Virol Methods 2006;2:325–333. doi: 10.1016/j.jviromet.2006.07.004.
104. Jothikumar N, Cromeans TL, Robertson BH, Meng XJ, Hill VR. A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virus. J Virol Methods 2006;131:65–71. doi: 10.1016/j.jvir-omet.2005.07.004.
105. Barnaud E, Rogée S, Garry P, Rose N, Pavio N. Thermal inactivation of infectious hepatitis E virus in experimentally contaminated food. Appl Envi-ron Microbiol 2012;78:5153–5159. doi: 10.1128/AEM.00436-12.
106. Bouwknegt M, Engel B, Herremans MM, Widdowson MA, Worm HC, Koop-mans MP, et al. Bayesian estimation of hepatitis E virus seroprevalence for populations with different exposure levels to swine in the Netherlands. Epi-demiol Infect 2008;136:567–576. doi: 10.1017/S0950268807008941.
107. Kasorndorkbua C, Thacker BJ, Halbur PG, Guenette DK, Buitenwerf RM, Royer RL, et al. Experimental infection of pregnant gilts with swine hepatitis E virus. Can J Vet Res 2003;67:303–306.
108. Hakze-van der Honing RW, van Coillie E, Antonis AF, van der Poel WH. First isolation of hepatitis E virus genotype 4 in Europe through swine surveillance in the Netherlands and Belgium. PLoS One 2011;6:e22673. doi: 10. 1371/journal.pone.0022673.
109. http://apps.who.int/iris/bitstream/10665/129448/1/9789241507608_eng. pdf?ua=1, accessed March 2015.
110. Purcell RH, Nguyen H, Shapiro M, Engle RE, Govindarajan S, Blackwelder WC, et al. Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine. Vaccine 2003;21:2607–2615. doi: 10.1016/S0264-410X(03)00100-2.
111. Goel A, Aggarwal R. Prevention of hepatitis E: another step forward. Future Microbiol 2011;6:23–27. doi: 10.2217/fmb.10.151.
112. Kamili S, Spelbring J, Carson D, Krawczynski K. Protective efficacy of hepatitis E virus DNA vaccine administered by gene gun in the cynomolgus macaque model of infection. J Infect Dis 2004;189:258–264. doi: 10. 1086/380801.
113. Shrestha MP, Scott RM, Joshi DM, Mammen MP Jr, Thapa GB, Thapa N, et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 2007; 356:895–903. doi: 10.1056/NEJMoa061847.
114. Li SW, Zhang J, Li YM, Ou SH, Huang GY, He ZQ, et al. A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Vaccine 2005;23:2893–2901. doi: 10. 1016/j.vaccine.2004.11.064.
115. Zhang J, Liu CB, Li RC, Li YM, Zheng YJ, Li YP, et al. Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine. Vaccine 2009;27:1869–1874. doi: 10.1016/j.vaccine.2008.12. 061.
116. Zhu FC, Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010; 376:895–902. doi: 10.1016/S0140-6736(10)61030-6.
117. Park SB. Hepatitis E vaccine debuts. Nature 2012;7422:21–22. doi: 10. 1038/491021a.
118. Li SW, Zhao Q, Wu T, Chen S, Zhang J, Xia NS. The development of a recombinant hepatitis E vaccine HEV 239. Hum Vaccin Immunother 2015; 11:908–914. doi:10.1080/21645515.2015.1008870.
119. Zhang J, Zhang XF, Huang SJ, Wu T, Hu YM, Wang ZZ, et al. Long-term efficacy of a hepatitis E vaccine. N Eng J Med 2015;372:914–922. doi: 10.1056/NEJMoa1406011.